IPS TMS for Patients with PTSD

IPS TMS for Patients with PTSD
Recruiting
18 years - 60 years
All
Phase 1
120 participants needed
1 Location

Brief description of study

This study will be the first of its kind to explore the impact of continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) on arousal symptoms among patients with posttraumatic stress disorder (PTSD). We will demonstrate that IPS cTBS results in significant target engagement in the form of reduction in anxiety-potentiated startle (APS) compared to sham cTBS and will identify the ideal dose of cTBS.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: PTSD
  • Age: 18 years - 60 years
  • Gender: All

Male or Female, Age 18-60, Diagnosed with PTSD, right-handed, no metal implants, not pregnant, no history of seizures/seizure disorders, ability to read and write in English

Updated on 02 Jul 2025. Study ID: 21-0951

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center